Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?

Detalles Bibliográficos
Autores principales: Omarjee, Loukman, Meilhac, Olivier, Perrot, Frédérique, Janin, Anne, Mahe, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240255/
https://www.ncbi.nlm.nih.gov/pubmed/32445671
http://dx.doi.org/10.1016/j.clim.2020.108468
_version_ 1783536843602526208
author Omarjee, Loukman
Meilhac, Olivier
Perrot, Frédérique
Janin, Anne
Mahe, Guillaume
author_facet Omarjee, Loukman
Meilhac, Olivier
Perrot, Frédérique
Janin, Anne
Mahe, Guillaume
author_sort Omarjee, Loukman
collection PubMed
description
format Online
Article
Text
id pubmed-7240255
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72402552020-05-21 Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19? Omarjee, Loukman Meilhac, Olivier Perrot, Frédérique Janin, Anne Mahe, Guillaume Clin Immunol Article Elsevier Inc. 2020-07 2020-05-21 /pmc/articles/PMC7240255/ /pubmed/32445671 http://dx.doi.org/10.1016/j.clim.2020.108468 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Omarjee, Loukman
Meilhac, Olivier
Perrot, Frédérique
Janin, Anne
Mahe, Guillaume
Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
title Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
title_full Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
title_fullStr Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
title_full_unstemmed Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
title_short Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19?
title_sort can ticagrelor be used to prevent sepsis-induced coagulopathy in covid-19?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240255/
https://www.ncbi.nlm.nih.gov/pubmed/32445671
http://dx.doi.org/10.1016/j.clim.2020.108468
work_keys_str_mv AT omarjeeloukman canticagrelorbeusedtopreventsepsisinducedcoagulopathyincovid19
AT meilhacolivier canticagrelorbeusedtopreventsepsisinducedcoagulopathyincovid19
AT perrotfrederique canticagrelorbeusedtopreventsepsisinducedcoagulopathyincovid19
AT janinanne canticagrelorbeusedtopreventsepsisinducedcoagulopathyincovid19
AT maheguillaume canticagrelorbeusedtopreventsepsisinducedcoagulopathyincovid19

Ejemplares similares